EMA
- Application: EMEA/H/C/004196
- Local brand name: Varuby
- Status: withdrawn
Varubi (ROLAPITANT) regulatory status in European Union.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA has authorised it.
Tersera is the originator. The local marketing authorisation holder may differ — check the official source linked above.